Latest / Evidence at the Bedside
COPD Pharmacologic Management | 2020 ATS Guideline Explained
In this episode of Evidence at the Bedside, we break down the 2020 American Thoracic Society (ATS) Clinical Practice Guideline on the pharmacologic management of chronic obstructive pulmonary disease (COPD). We review high-yield, bedside-relevant recommendations including: When to use LABA/LAMA combination therapy over monotherapy. Indications for triple therapy (ICS/LABA/LAMA). When to consider ICS withdrawal. The role of blood eosinophils in ICS decision-making. Why maintenance oral steroids are discouraged. Opioids for refractory dyspnea.
We translate GRADE-based recommendations into…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.